CONFIDENTIAL
CONFIDENTIAL

OFFERING MEMORANDUM

Senior Secured Loan-Stock Pledge Financing

SOVR Development Holdings, LLC
dba SOVR Empire

Wyoming Limited Liability Company

Private Credit Transaction — Not for Public Distribution

01

Important Notices

CONFIDENTIALITY NOTICE

This Confidential Offering Memorandum (the "Memorandum") has been prepared solely for the exclusive use of selected qualified institutional and professional lenders (each, a "Recipient") for the purpose of evaluating a proposed senior secured financing to SOVR Development Holdings, LLC dba SOVR Empire (the "Company").

By accepting delivery of this Memorandum, each Recipient agrees to: (i) maintain the strict confidentiality of all information contained herein; (ii) not copy, reproduce, disclose, or distribute this Memorandum or any portion thereof to any third party without the prior written consent of the Company; and (iii) return or destroy all copies of this Memorandum upon request or if the Recipient declines to pursue the financing opportunity.

Not a Public Offering

This Memorandum does not constitute an offer to sell, or a solicitation of an offer to buy, any securities to the public. The proposed financing is structured as a private credit transaction and is not registered under the Securities Act of 1933, as amended, or any state securities laws.

Forward-Looking Statements

This Memorandum contains forward-looking statements regarding the Company's business, financial condition, results of operations, and prospects. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Recipients should not place undue reliance on forward-looking statements, which speak only as of the date hereof.

Professional Advice

Recipients are advised to consult with their own legal, tax, accounting, and financial advisors before making any lending decision. The Company makes no representations regarding the tax consequences or accounting treatment of the proposed financing to any Recipient.

No Duty to Update

The Company undertakes no obligation to update or revise any forward-looking statements or other information contained in this Memorandum, whether as a result of new information, future events, or otherwise.

02

Table of Contents

01Executive Summary
02Offering Overview
03Investment Highlights
04Use of Proceeds
05Company Overview
06Capital Structure
07Security Package
08Key Loan Terms
09Collateral Valuation
10Oracle Ledger / Reporting Infrastructure
11Accounting Treatment
12Legal / Regulatory Framework
13Covenant Package
14Financial Covenants
15Events of Default
16Remedies
17Miscellaneous Legal Terms
18Exhibits / Schedules
19Execution Roadmap
20Contact Information
03

Executive Summary

SOVR Development Holdings, LLC dba SOVR Empire (the "Company"), a Wyoming limited liability company founded by Gustavo O Maldonado TTEE, is seeking senior secured financing through a loan-stock pledge structure. The financing is designed as a non-dilutive capital solution, providing the Company with growth capital while offering lenders robust security and downside protection.

400,000
Common Shares Pledged
Senior
Security Priority
SOFR +
Floating Rate Structure

Transaction Structure

The proposed financing features a senior secured loan structure with 400,000 Common Shares pledged as collateral. The Company will execute comprehensive loan documentation, security agreements, and pledge arrangements to provide lenders with first-priority security interests in the pledged shares.

Key Benefits to Lenders

  • First-priority security interest in 400,000 Common Shares
  • Comprehensive covenant package with quarterly testing
  • Equity cure rights with appropriate limitations
  • Professional-grade reporting infrastructure
  • Clear remedies and enforcement mechanisms
  • Institutional-quality documentation

Use of Proceeds

Proceeds from the financing will be deployed strategically to support the Company's growth initiatives, working capital requirements, and operational expansion. Detailed use of proceeds is outlined in Section 04 of this Memorandum.

04

Offering Overview

Term Description
Borrower SOVR Development Holdings, LLC (Wyoming LLC)
Transaction Type Senior Secured Loan with Stock Pledge
Collateral 400,000 Common Shares of the Company
Security Priority First-priority security interest, senior to all other claims except permitted liens
Interest Rate SOFR + applicable margin (subject to negotiation)
Rate Structure Floating rate based on Secured Overnight Financing Rate
Covenant Testing Quarterly as of each quarter-end
Reporting Compliance certificates within 45 days of quarter-end; annual independent audit
Documentation Institutional-grade loan agreements, security agreements, pledge agreements, and ancillary documents

Non-Dilutive Structure

This financing is structured to provide capital without diluting existing equity holders. The pledged shares serve as collateral security and do not transfer ownership unless an event of default occurs and remedies are exercised.

Professional Documentation

All transaction documentation will be prepared by experienced banking counsel and will conform to institutional lending standards. The documentation package will include comprehensive representations, warranties, covenants, and remedies provisions.

05

Investment Highlights

Strong Security Package

Lenders benefit from a first-priority security interest in 400,000 Common Shares, providing substantial downside protection and clear enforcement rights in the event of default.

Comprehensive Covenants

Illustrative financial covenant framework includes leverage ratios, coverage ratios, and operational restrictions designed to protect lender interests while allowing operational flexibility.

Transparent Reporting

Quarterly compliance certificates with detailed covenant calculations, annual independent audits, and ongoing financial reporting provide lenders with full visibility into the Company's performance.

Equity Cure Rights

Structured equity cure provisions allow the Company to remedy covenant breaches through capital injections, subject to appropriate limitations (max 2 per year, max 3 over loan term).

Clear Remedies

Well-defined events of default and remedy provisions provide lenders with multiple enforcement options, including acceleration, foreclosure on collateral, and appointment of receivers.

Institutional Standards

Transaction documentation and structure conform to institutional lending standards, facilitating potential syndication, participation, or secondary market transfers.

Risk Mitigation Features

  • First-priority perfected security interest in pledged shares
  • UCC-1 financing statements and control arrangements
  • Certificated share delivery with stock powers
  • Quarterly covenant testing with 45-day reporting window
  • Limited equity cure rights to prevent abuse
  • Comprehensive events of default provisions
  • Multiple remedy options upon default
06

Use of Proceeds

The proceeds from the proposed senior secured financing will be deployed strategically to support the Company's growth objectives and operational requirements. The Company has identified the following intended uses for the capital raised:

Growth Initiatives

Capital will be allocated to strategic growth initiatives, including market expansion, product development, and business line extensions. These investments are designed to enhance the Company's competitive position and long-term value creation.

Working Capital

A portion of proceeds will strengthen the Company's working capital position, providing operational flexibility and supporting day-to-day business activities. Enhanced working capital will improve the Company's ability to execute on strategic opportunities.

Capital Expenditures

Proceeds may be used for capital expenditures necessary to support business operations and growth. All capital expenditures will be subject to the financial covenants outlined in Section 14 of this Memorandum.

General Corporate Purposes

The Company may deploy proceeds for other general corporate purposes as determined by management and approved by the Board of Directors, subject to restrictions and covenants contained in the loan documentation.

Covenant Restrictions

The use of proceeds will be subject to the covenant package outlined in this Memorandum. Certain uses may require lender consent or may be restricted by negative covenants. Lenders will receive detailed reporting on the deployment of capital through quarterly compliance certificates.

07

Company Overview

Legal Structure

Legal Name SOVR Development Holdings, LLC
dba SOVR Empire
Entity Type Limited Liability Company
Jurisdiction Wyoming
EIN 39-2332625
D-U-N-S Number 13-682-4504
UID K752ULAXJV36
Registered Agent 2120 Carey Ave, Cheyenne, WY 82001
Operations Address 3704 Loudon St, Bakersfield, CA 93313
Governance Board of Directors and Members

Business Description

SOVR Development Holdings, LLC (dba SOVR Empire) is a Wyoming-based limited liability company founded by Gustavo O Maldonado TTEE, who serves as Founder and Trustee. Mr. Maldonado is a Web3 Vault Architect, Trust Law Strategist, Real-Time Payment Systems expert, and Builder of Tokenized Credit Ecosystems. The Company operates with a focus on sustainable growth, operational excellence, and value creation for stakeholders through innovative blockchain and credit ecosystem solutions.

Corporate Governance

The Company maintains institutional-grade corporate governance practices, including:

  • Active Board of Directors oversight
  • Regular member meetings and approvals
  • Professional management team
  • Independent financial and legal advisors
  • Comprehensive compliance and reporting systems

Authorization for Financing

The proposed financing transaction has been authorized by the Company's Board of Directors and, where required, by the Members. All necessary corporate approvals and authorizations will be documented and delivered to lenders as conditions precedent to funding.

08

Capital Structure

Equity Capitalization

The Company's equity structure consists of Common Shares issued to Members. The proposed financing involves the pledge of 400,000 Common Shares as collateral security for the senior secured loan.

Pledged Collateral

Collateral Type Quantity Security Priority
Common Shares 400,000 shares First-priority security interest

Debt Structure

Upon closing of the proposed financing, the Company's debt structure will consist of:

  • Senior Secured Loan (this transaction) - First priority
  • Existing debt obligations (if any) - Subject to subordination or permitted lien status

Capitalization Table

A detailed capitalization table showing all equity ownership, outstanding debt, and security interests will be provided to lenders during due diligence. The table will clearly identify all existing liens and encumbrances on Company assets.

Permitted Liens

The loan documentation will specify permitted liens that may rank pari passu with or senior to the lenders' security interest. Typical permitted liens include tax liens, statutory liens, and other customary exceptions. All permitted liens will be clearly defined in the security agreement.

09

Security Package

Collateral Description

The lenders will receive a first-priority perfected security interest in 400,000 Common Shares of SOVR Development Holdings, LLC. The security interest will be perfected through multiple mechanisms to ensure maximum protection.

Perfection Methods

  • UCC-1 Financing Statements: Filed in Wyoming and other applicable jurisdictions
  • Control Arrangements: Lender control over certificated shares
  • Certificated Share Delivery: Physical delivery of share certificates to lender or custodian
  • Stock Powers: Executed stock powers delivered to lender
  • Custodial Acknowledgements: Third-party custodian acknowledgements where applicable
  • Additional Perfection Steps: Any additional steps required by lender counsel

Priority Objective

The security package is designed to achieve first-priority status, meaning the lenders' security interest will be senior to all other claims against the pledged shares, except for expressly permitted liens. Lien searches and priority confirmations will be conducted as part of closing conditions.

Valid Security Interest Requirements

To establish a valid and enforceable security interest, the following elements must be satisfied:

  • Value: Lender provides value (loan proceeds) to the Company
  • Rights in Collateral: Company has rights in the pledged shares
  • Authenticated Security Agreement: Executed security agreement describing the collateral
  • Perfection: Security interest perfected through appropriate methods

Security Agreement Terms

The security agreement will contain comprehensive provisions addressing:

  • Detailed description of pledged shares
  • Representations and warranties regarding the collateral
  • Covenants related to maintenance and protection of collateral
  • Rights and remedies upon default
  • Procedures for foreclosure and sale of collateral
  • Application of proceeds from collateral liquidation

Collateral Maintenance Covenants

The Company will covenant to maintain the value and priority of the pledged collateral, including obligations to:

  • Maintain corporate good standing and share validity
  • Refrain from creating additional liens on pledged shares
  • Provide notice of any claims or encumbrances
  • Execute additional documents as reasonably requested by lender
  • Cooperate with lender's periodic collateral audits
10

Key Loan Terms

Interest Rate Structure

The loan will bear interest at a floating rate based on the Secured Overnight Financing Rate (SOFR) plus an applicable margin to be negotiated between the parties. All LIBOR references have been eliminated in favor of SOFR-based pricing.

Component Description
Base Rate SOFR (Secured Overnight Financing Rate)
Margin To be negotiated based on credit profile and market conditions
Rate Reset Periodic reset based on SOFR conventions
Floor SOFR floor (if applicable) to be negotiated

Repayment Terms

Repayment terms, including principal amortization schedule, maturity date, and prepayment provisions, will be subject to negotiation between the Company and lenders. The loan documentation will specify:

  • Principal repayment schedule (if amortizing)
  • Interest payment frequency (typically quarterly)
  • Final maturity date
  • Mandatory prepayment events
  • Voluntary prepayment rights and premiums (if any)

Fees and Expenses

The loan structure may include various fees, including:

  • Origination or arrangement fee
  • Commitment fee (if applicable)
  • Agency fees (if syndicated)
  • Legal and documentation expenses
  • Ongoing administrative fees

Illustrative Loan Terms Summary

The following terms are illustrative and subject to final negotiation:

Loan Amount To be determined based on collateral value and credit analysis
Interest Rate SOFR + applicable margin
Maturity To be negotiated (typically 3-5 years)
Amortization Subject to negotiation (bullet, amortizing, or hybrid)
Prepayment Subject to negotiation (may include premiums)
11

Collateral Valuation

Valuation Methodology

The valuation of the pledged 400,000 Common Shares will be established through a rigorous analysis conducted by the lenders and their advisors. The valuation process will consider multiple methodologies and factors to determine appropriate loan-to-value ratios.

Valuation Approaches

Lenders may employ one or more of the following valuation methodologies:

  • Comparable Company Analysis: Valuation based on public company comparables
  • Precedent Transaction Analysis: Valuation based on recent M&A transactions
  • Discounted Cash Flow: Present value of projected future cash flows
  • Asset-Based Valuation: Net asset value approach
  • Independent Appraisal: Third-party valuation expert assessment

Loan-to-Value Considerations

The loan amount will be sized based on a conservative loan-to-value (LTV) ratio to provide lenders with adequate collateral coverage. Typical LTV ratios for stock pledge transactions range from 50% to 70%, depending on:

  • Liquidity and marketability of shares
  • Volatility and risk profile
  • Company financial strength
  • Market conditions
  • Covenant package strength

Ongoing Valuation Monitoring

The loan documentation may require periodic revaluation of the pledged shares to ensure adequate collateral coverage throughout the loan term. If collateral value declines below specified thresholds, the Company may be required to:

  • Pledge additional shares or collateral
  • Make principal prepayments to restore LTV ratios
  • Provide alternative credit support

Valuation Disclosure

Detailed valuation analysis, including methodologies, assumptions, and conclusions, will be provided to prospective lenders during the due diligence process. The Company will cooperate fully with lenders' valuation advisors and provide all requested financial and operational information.

12

Oracle Ledger / Reporting Infrastructure

Reporting Framework

The Company will maintain a comprehensive reporting infrastructure to provide lenders with timely, accurate, and detailed information regarding financial performance, covenant compliance, and collateral status.

Quarterly Reporting Requirements

Within 45 days of each quarter-end, the Company will deliver to lenders:

  • Compliance Certificate: Officer certification of covenant compliance with detailed calculations
  • Financial Statements: Quarterly financial statements (balance sheet, income statement, cash flow statement)
  • Covenant Calculations: Detailed schedules showing all financial covenant calculations
  • Collateral Status Report: Confirmation of pledged share status and any changes
  • Management Discussion: Narrative discussion of quarterly results and outlook

Annual Reporting Requirements

Within 90 days of each fiscal year-end, the Company will deliver:

  • Audited Financial Statements: Annual financial statements audited by independent CPA firm
  • Auditor's Report: Unqualified opinion from independent auditor
  • Annual Compliance Certificate: Year-end covenant compliance certification
  • Management Letter: Any management letters or recommendations from auditors
  • Annual Budget: Budget and projections for upcoming fiscal year

Event-Driven Reporting

The Company will promptly notify lenders of certain material events, including:

  • Events of default or potential defaults
  • Material litigation or regulatory actions
  • Changes in management or control
  • Proposed material transactions
  • Material adverse changes in business or financial condition

Lender Access Rights

Lenders will have reasonable access to:

  • Company's books and records
  • Management for discussions and updates
  • Facilities and operations (with reasonable notice)
  • Independent auditors and other advisors
13

Accounting Treatment

Loan Accounting

The senior secured loan will be recorded as a liability on the Company's balance sheet at the principal amount outstanding. Interest expense will be recognized on an accrual basis in accordance with Generally Accepted Accounting Principles (GAAP).

Collateral Accounting

The pledge of 400,000 Common Shares as collateral does not result in derecognition of the equity. The shares remain on the Company's books as equity, subject to disclosure of the pledge and security interest in the financial statement footnotes.

Equity Cure Accounting

When the Company exercises equity cure rights by injecting additional capital:

  • The capital contribution is recorded as additional equity
  • For covenant calculation purposes, the equity contribution is treated as EBITDA in the period of cure
  • Detailed disclosure of equity cure usage will be provided in compliance certificates

Financial Statement Disclosure

The Company's financial statements will include appropriate disclosures regarding:

  • Terms and conditions of the senior secured loan
  • Pledged shares and security interests
  • Covenant requirements and compliance status
  • Contingencies and commitments
  • Related party transactions (if applicable)

Tax Treatment

Recipients should consult with their own tax advisors regarding the tax treatment of the loan transaction. The Company makes no representations regarding tax consequences to lenders. Tax treatment may vary based on lender type, jurisdiction, and other factors.

15

Covenant Package

Illustrative Covenant Framework

The following covenant package is illustrative and subject to lender diligence and final negotiation. The actual covenant package will be tailored based on the Company's business model, financial profile, and lender requirements.

Affirmative Covenants

The Company will covenant to:

  • Financial Reporting: Deliver quarterly and annual financial statements and compliance certificates
  • Maintain Existence: Preserve corporate existence and good standing
  • Maintain Insurance: Maintain adequate insurance coverage
  • Pay Obligations: Pay taxes and other obligations when due
  • Comply with Laws: Comply with all applicable laws and regulations
  • Maintain Properties: Maintain properties and assets in good condition
  • Maintain Books and Records: Keep proper books and records
  • Provide Access: Provide lenders with reasonable access to facilities and information

Negative Covenants

The Company will covenant not to (without lender consent):

  • Indebtedness: Incur additional indebtedness beyond specified limits
  • Liens: Create liens on assets except permitted liens
  • Restricted Payments: Make dividends or distributions beyond specified limits
  • Investments: Make investments or acquisitions beyond specified limits
  • Asset Sales: Sell or dispose of material assets
  • Fundamental Changes: Merge, consolidate, or undergo change of control
  • Transactions with Affiliates: Engage in non-arm's length affiliate transactions
  • Change in Business: Materially change nature of business
  • Amendments: Amend organizational documents in manner adverse to lenders

Permitted Exceptions

The negative covenants will include customary exceptions and baskets for:

  • Existing indebtedness and liens disclosed in schedules
  • Ordinary course trade payables
  • Permitted capital expenditures within specified limits
  • Ordinary course operating expenses and working capital needs
  • Permitted investments in subsidiaries and joint ventures
16

Financial Covenants

Illustrative Financial Covenant Framework

The financial covenants outlined below are illustrative examples subject to lender diligence and final negotiation. Actual covenant levels will be established based on the Company's historical performance, projections, and industry benchmarks.

Covenant Testing Framework

Element Description
Testing Frequency Quarterly as of each quarter-end
Compliance Certificate Detailed calculations within 45 days of quarter-end
Annual Verification Independent auditor verification of year-end covenant compliance
Cure Rights Equity cure rights available (subject to limitations)

Illustrative Leverage Covenant

Maximum Total Debt / EBITDA Ratio

The Company shall maintain a ratio of Total Debt to EBITDA (calculated on a trailing twelve-month basis) not to exceed [X.XX]:1.00, tested quarterly.

Definitions:

  • Total Debt: All outstanding indebtedness for borrowed money, including the senior secured loan
  • EBITDA: Earnings before interest, taxes, depreciation, and amortization, with customary adjustments

Illustrative Coverage Covenant

Minimum Debt Service Coverage Ratio

The Company shall maintain a ratio of EBITDA to Debt Service (calculated on a trailing twelve-month basis) of at least [X.XX]:1.00, tested quarterly.

Definitions:

  • Debt Service: Principal and interest payments on all indebtedness during the measurement period
  • EBITDA: As defined above

Illustrative Capital Expenditure Covenant

Maximum Annual Capital Expenditures

The Company shall not make capital expenditures in any fiscal year exceeding the lesser of:

  • $[X,XXX,XXX] per fiscal year, or
  • [XX]% of revenue for such fiscal year

Example:

If the covenant limit is the lesser of $2,000,000 or 15% of revenue, and actual capital expenditures are $1,800,000, the Company is in compliance.

Equity Cure Rights

If the Company fails to comply with financial covenants, it may cure the breach by injecting additional equity capital, subject to the following limitations:

Parameter Limitation
Cure Timeline 15 days from quarter-end to inject additional capital
Accounting Treatment Equity contribution treated as EBITDA for covenant calculation purposes
Annual Limit Maximum of 2 equity cures per year
Loan Term Limit Maximum of 3 equity cures over loan term
Amount Requirement Sufficient to achieve compliance with all failed covenants

Covenant Calculation Methodology

All financial covenant calculations will be performed in accordance with GAAP, consistently applied, with adjustments as specifically defined in the loan agreement. The compliance certificate will include detailed schedules showing all calculations, adjustments, and supporting data.

17

Events of Default

Payment Defaults

  • Failure to pay principal when due
  • Failure to pay interest within [X] days of due date
  • Failure to pay fees or other amounts within [X] days of due date

Covenant Defaults

  • Breach of financial covenants (subject to equity cure rights)
  • Breach of affirmative covenants, uncured for [X] days after notice
  • Breach of negative covenants

Representation and Warranty Defaults

  • Material misrepresentation or warranty proves to be incorrect
  • Failure to correct or cure within specified period

Cross-Default Provisions

  • Default under other material indebtedness
  • Acceleration of other material indebtedness
  • Failure to pay other material indebtedness when due

Bankruptcy and Insolvency Events

  • Voluntary bankruptcy or insolvency petition
  • Involuntary bankruptcy petition not dismissed within [X] days
  • Appointment of receiver or trustee
  • General assignment for benefit of creditors
  • Admission of inability to pay debts

Material Adverse Change

  • Material adverse change in business, financial condition, or operations
  • Material adverse effect on ability to perform obligations
  • Material adverse effect on validity or enforceability of loan documents

Change of Control

  • Change in ownership or control without lender consent
  • Sale of all or substantially all assets
  • Merger or consolidation without lender consent

Judgment and Litigation Defaults

  • Entry of final judgment exceeding specified threshold, unstayed and unsatisfied for [X] days
  • Material litigation or regulatory action threatening business viability

Cure Periods and Notice Requirements

Certain events of default will be subject to cure periods and notice requirements, allowing the Company to remedy breaches before acceleration. Payment defaults and bankruptcy events typically have no cure period, while covenant breaches may have [X] to [X] day cure periods.

18

Remedies

Acceleration

Upon the occurrence and continuation of an Event of Default, lenders may declare all outstanding principal, accrued interest, and other amounts immediately due and payable. Acceleration may be automatic for certain events (bankruptcy) or require lender action for others.

Foreclosure on Collateral

Lenders may foreclose on the pledged 400,000 Common Shares through:

  • Public Sale: Sale at public auction in accordance with UCC provisions
  • Private Sale: Private sale to qualified purchasers
  • Retention: Retention of collateral in satisfaction of debt (strict foreclosure)
  • Other Methods: Any other method permitted by law

All foreclosure sales will be conducted in a commercially reasonable manner with appropriate notice to the Company.

Application of Proceeds

Proceeds from collateral liquidation will be applied in the following order:

  1. Costs and expenses of foreclosure and sale
  2. Accrued and unpaid interest
  3. Outstanding principal
  4. Other amounts owed to lenders
  5. Surplus (if any) returned to Company

Appointment of Receiver

Lenders may seek appointment of a receiver to take possession of collateral and/or Company assets, collect revenues, and manage operations pending resolution of the default.

Enforcement of Security Interest

Lenders may exercise all rights and remedies available under the UCC and applicable law, including:

  • Taking possession of pledged shares
  • Exercising voting rights associated with shares
  • Collecting dividends and distributions
  • Transferring shares to lender or third party purchaser

Litigation and Legal Action

Lenders may pursue legal action to:

  • Obtain judgment for amounts owed
  • Enforce loan and security documents
  • Obtain injunctive relief
  • Pursue other legal and equitable remedies

Set-Off Rights

Lenders may set off any amounts owed by lender to Company against amounts owed by Company to lender, to the extent permitted by law.

Cumulative Remedies

All remedies are cumulative and non-exclusive. Exercise of one remedy does not preclude exercise of other remedies. Lenders may pursue multiple remedies simultaneously or sequentially as deemed appropriate.

Commercial Reasonableness

All remedies will be exercised in a commercially reasonable manner in accordance with applicable law. The Company will receive appropriate notice of foreclosure sales and other remedy actions as required by the UCC and other applicable laws.

20

Exhibits / Schedules

Required Exhibits

The following exhibits will be attached to the loan documentation:

  • Exhibit A: Form of Compliance Certificate
  • Exhibit B: Form of Officer's Certificate
  • Exhibit C: Form of Legal Opinion
  • Exhibit D: Form of Assignment and Assumption Agreement
  • Exhibit E: Financial Covenant Definitions and Calculations
  • Exhibit F: Permitted Liens Schedule
  • Exhibit G: Permitted Indebtedness Schedule

Required Schedules

The following schedules will provide detailed disclosure:

  • Schedule 1: Capitalization Table and Ownership Structure
  • Schedule 2: Existing Indebtedness
  • Schedule 3: Existing Liens and Encumbrances
  • Schedule 4: Material Contracts
  • Schedule 5: Litigation and Disputes
  • Schedule 6: Environmental Matters
  • Schedule 7: Intellectual Property
  • Schedule 8: Real Property and Leases
  • Schedule 9: Subsidiaries and Affiliates
  • Schedule 10: Insurance Policies

Disclosure Standards

All schedules must provide complete and accurate disclosure of material information. The Company represents that schedules are true, complete, and correct as of the closing date. Updates to schedules may be required if material changes occur during the loan term.

21

Execution Roadmap

Transaction Timeline

The following roadmap outlines the key phases and milestones for executing the proposed financing transaction. Actual timing may vary based on due diligence findings, documentation negotiations, and market conditions.

Phase 1: Preparation and Documentation (Weeks 1-4)

Week 1 Activities:

  • Engage legal counsel (banking and corporate)
  • Engage financial advisors
  • Prepare preliminary term sheet

Responsible Parties: Legal counsel, financial advisors, Company management

Phase 2: Lender Identification and Outreach (Weeks 2-5)

  • Identify target lender universe
  • Prepare confidential offering memorandum
  • Conduct initial lender meetings
  • Distribute offering materials to qualified lenders

Responsible Parties: Financial advisors, Company management

Phase 3: Due Diligence (Weeks 4-8)

  • Establish virtual data room
  • Respond to lender due diligence requests
  • Conduct management presentations
  • Facilitate site visits (if requested)
  • Coordinate with advisors on technical diligence

Responsible Parties: Company management, advisors, lenders

Phase 4: Term Sheet Negotiation (Weeks 6-9)

  • Receive and evaluate term sheet proposals
  • Negotiate key terms and conditions
  • Select lead lender or lending group
  • Execute term sheet or commitment letter

Responsible Parties: Company management, legal counsel, financial advisors

Phase 5: Documentation (Weeks 8-12)

  • Draft loan agreement and security documents
  • Negotiate documentation with lender counsel
  • Prepare closing deliverables and schedules
  • Obtain corporate approvals and authorizations
  • Prepare legal opinions

Responsible Parties: Legal counsel (Company and lender), Company management

Phase 6: Closing (Week 12-13)

  • Satisfy conditions precedent to closing
  • Execute final documentation
  • Deliver closing certificates and opinions
  • File UCC-1 financing statements
  • Deliver pledged share certificates
  • Fund loan proceeds

Responsible Parties: All parties, legal counsel, administrative agent

Phase 7: Post-Closing (Ongoing)

  • Establish reporting and compliance systems
  • Deliver initial compliance certificate
  • Implement ongoing covenant monitoring
  • Maintain lender relationships and communications

Responsible Parties: Company management, finance team, legal counsel

Critical Success Factors

  • Early engagement of experienced legal and financial advisors
  • Comprehensive due diligence preparation and data room organization
  • Clear communication of business model and growth strategy
  • Realistic covenant negotiation balancing flexibility and lender protection
  • Efficient documentation process with experienced counsel
  • Proactive management of closing conditions and deliverables
22

Contact Information

Company Contact

Company Name SOVR Development Holdings, LLC
dba SOVR Empire
Operations Address 3704 Loudon St, Bakersfield, CA 93313
Registered Agent 2120 Carey Ave, Cheyenne, WY 82001
Email admin@sovr.credit
SOVR.Empire@sovr.credit
EIN 39-2332625
D-U-N-S 13-682-4504
UID K752ULAXJV36

Management Contacts

Founder & Trustee

Gustavo O Maldonado TTEE
SOVR.Empire@sovr.credit
Founder of SOVR Empire | Web3 Vault Architect | Trust Law Strategist | Real-Time Payment Systems | Builder of Tokenized Credit Ecosystems

Legal Counsel

Company Counsel

[Law Firm Name]
[Attorney Name]
[Address]
[Email]
[Phone]

Financial Advisors

Investment Bank / Financial Advisor

[Firm Name]
[Advisor Name]
[Address]
[Email]
[Phone]

Inquiries and Due Diligence Requests

Qualified institutional lenders interested in this financing opportunity should direct inquiries to the contacts listed above. Due diligence requests and data room access will be facilitated through the Company's financial advisors upon execution of appropriate confidentiality agreements.

Member Approval and Authorization

The undersigned Members of SOVR Development Holdings, LLC dba SOVR Empire hereby approve all actions taken or to be taken by the Board of Directors and officers of the Company in connection with the financing transactions contemplated by this Offering Memorandum.

Member Signature:

Signature

Print Name:

Gustavo Orona Maldonado

Title:

Founder & Trustee

Date:

March 30, 2026

made with